Morgan Stanley Thinks DraftKings Has Potential For Improving Parlay Mix & Hold
Morgan Stanley analyst Stephen Grambling reiterated an Overweight rating on the shares of DraftKings Inc (NASDAQ:DKNG) and raised the price target from…
TJX’s In-Line Quarter Despite Macro Pressures Win Analyst Conviction
Telsey Advisory Group analyst Dana Telsey reiterated an Outperform rating on the shares of TJX Companies Inc (NYSE:TJX) with a price target…
These 6 Palo Alto Networks Analysts Are Happy With FQ2 Print
Shares of Palo Alto Networks Inc (NASDAQ: PANW) jumped in Wednesday’s premarket session, after the company reported quarterly earnings.
Cowen & Co. Reiterates Outperform on Wingstop, Maintains $180 Price Target
Cowen & Co. analyst Andrew Charles reiterates Wingstop (NASDAQ:WING) with a Outperform and maintains $180 price target.
JMP Securities Reiterates Market Outperform on CoStar Gr, Maintains $85 Price Target
JMP Securities analyst Joe Goodwin reiterates CoStar Gr (NASDAQ:CSGP) with a Market Outperform and maintains $85 price target.
JMP Securities Reiterates Market Outperform on Backblaze, Maintains $18 Price Target
JMP Securities analyst Erik Suppiger reiterates Backblaze (NASDAQ:BLZE) with a Market Outperform and maintains $18 price target.
JMP Securities Reiterates Market Outperform on Halozyme Therapeutics, Raises Price Target to $66
JMP Securities analyst Jason Butler reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Market Outperform and raises the price target from $62 to $66.
Credit Suisse Reiterates Outperform on AbCellera Biologics, Maintains $34 Price Target
Credit Suisse analyst Tiago Fauth reiterates AbCellera Biologics (NASDAQ:ABCL) with a Outperform and maintains $34 price target.
Credit Suisse Reiterates Neutral on TPG, Maintains $36 Price Target
Credit Suisse analyst Bill Katz reiterates TPG (NASDAQ:TPG) with a Neutral and maintains $36 price target.
Needham Reiterates Buy on Adtran, Maintains $28 Price Target
Needham analyst Ryan Koontz reiterates Adtran (NASDAQ:ADTN) with a Buy and maintains $28 price target.